debutylbupivacaine

CAS No. 15883-20-2

debutylbupivacaine( Desbutylbupivacaine | Debutylbupivacaine | Demethylmepivacaine )

Catalog No. M12267 CAS No. 15883-20-2

It is the intermediate of Ropivacaine Hydrochloride and Bupivacain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 43 In Stock
100MG 63 In Stock
200MG Get Quote In Stock
500MG 155 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    debutylbupivacaine
  • Note
    Research use only, not for human use.
  • Brief Description
    It is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
  • Description
    It is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Desbutylbupivacaine | Debutylbupivacaine | Demethylmepivacaine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    15883-20-2
  • Formula Weight
    232.32
  • Molecular Formula
    C14H20N2O
  • Purity
    >98% (HPLC)
  • Solubility
    Limited solubility
  • SMILES
    O=C(C1NCCCC1)NC2=C(C)C=CC=C2C
  • Chemical Name
    2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Pihlajam?ki K, et al. Br J Anaesth. 1990 May;64(5):556-62.
molnova catalog
related products
  • Acebilustat

    Acebilustat (CTX-4430, EP-501)?is a potent and selective leukotriene A4 hydrolase (LTA4H) inhibitor with IC50 of 64 nM for inhibition of LTB4 production in human whole blood.

  • Arjunic acid

    Arjunic acid is a strong antioxidant and a free radical scavenger. Arjunic acid shows activity against Gram-positive and Gram-negative bacteria with MIC values ranging between 1.9 and 15.6 microg/mL.

  • erythro-Austrobailig...

    erythro-Austrobailignan-6 is an orally active anti-cancer agent. erythro-Austrobailignan-6 inhibits DNA topoisomerase I and II activity. erythro-Austrobailignan-6 induces cell apoptosis and increases phosphorylation of p38 and JNK.